These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18677986)

  • 1. Policies for chemical hazard and risk priority setting: can persistence, bioaccumulation, toxicity, and quantity information be combined?
    Arnot JA; Mackay D
    Environ Sci Technol; 2008 Jul; 42(13):4648-54. PubMed ID: 18677986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prioritization of reproductive toxicants in unconventional oil and gas operations using a multi-country regulatory data-driven hazard assessment.
    Inayat-Hussain SH; Fukumura M; Muiz Aziz A; Jin CM; Jin LW; Garcia-Milian R; Vasiliou V; Deziel NC
    Environ Int; 2018 Aug; 117():348-358. PubMed ID: 29793188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tools for the prioritization of substances on the Domestic Substances List in Canada on the basis of hazard.
    Hughes K; Paterson J; Meek ME
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):382-93. PubMed ID: 19766685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated testing and intelligent assessment-new challenges under REACH.
    Ahlers J; Stock F; Werschkun B
    Environ Sci Pollut Res Int; 2008 Oct; 15(7):565-72. PubMed ID: 18818964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBT assessment and prioritization by PBT Index and consensus modeling: comparison of screening results from structural models.
    Gramatica P; Cassani S; Sangion A
    Environ Int; 2015 Apr; 77():25-34. PubMed ID: 25617903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling exposure to persistent chemicals in hazard and risk assessment.
    Cowan-Ellsberry CE; McLachlan MS; Arnot JA; Macleod M; McKone TE; Wania F
    Integr Environ Assess Manag; 2009 Oct; 5(4):662-79. PubMed ID: 19552503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the validity of classifying chemicals for persistence, bioaccumulation, toxicity, and potential for long-range transport.
    Mackay D; McCarty LS; MacLeod M
    Environ Toxicol Chem; 2001 Jul; 20(7):1491-8. PubMed ID: 11434289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of persistence in chemical evaluations.
    Mackay D; Hughes DM; Romano ML; Bonnell M
    Integr Environ Assess Manag; 2014 Oct; 10(4):588-94. PubMed ID: 24753402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of the basic hazard index screening for health risks associated with simultaneous exposure to multiple chemicals using a standardized target organ and systems framework.
    Adams VH; McAtee MJ; Johnson MS
    Integr Environ Assess Manag; 2017 Sep; 13(5):852-860. PubMed ID: 28135038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A methodology for ranking and hazard identification of xenobiotic organic compounds in urban stormwater.
    Baun A; Eriksson E; Ledin A; Mikkelsen PS
    Sci Total Environ; 2006 Oct; 370(1):29-38. PubMed ID: 16814849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioaccumulation of organic contaminants in humans: a multimedia perspective and the importance of biotransformation.
    McLachlan MS; Czub G; MacLeod M; Arnot JA
    Environ Sci Technol; 2011 Jan; 45(1):197-202. PubMed ID: 20701275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulating chemicals--from risks to riskiness.
    Chapman A
    Risk Anal; 2006 Jun; 26(3):603-16. PubMed ID: 16834621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are there other persistent organic pollutants? A challenge for environmental chemists.
    Muir DC; Howard PH
    Environ Sci Technol; 2006 Dec; 40(23):7157-66. PubMed ID: 17180962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for PBT chemicals among the "existing" and "new" chemicals of the EU.
    Strempel S; Scheringer M; Ng CA; Hungerbühler K
    Environ Sci Technol; 2012 Jun; 46(11):5680-7. PubMed ID: 22494215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using publicly available information to create exposure and risk-based ranking of chemicals used in the workplace and consumer products.
    Jayjock MA; Chaisson CF; Franklin CA; Arnold S; Price PS
    J Expo Sci Environ Epidemiol; 2009 Jul; 19(5):515-24. PubMed ID: 18685562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of human biomonitoring (HBM) of chemical exposure in the characterisation of health risks under REACH.
    Boogaard PJ; Aylward LL; Hays SM
    Int J Hyg Environ Health; 2012 Feb; 215(2):238-41. PubMed ID: 22177527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of EU risk assessments existing chemicals (EC Regulation 793/93).
    Bodar CW; Berthault F; de Bruijn JH; van Leeuwen CJ; Pronk ME; Vermeire TG
    Chemosphere; 2003 Dec; 53(8):1039-47. PubMed ID: 14505727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human health screening level risk assessments of tertiary-butyl acetate (TBAC): calculated acute and chronic reference concentration (RfC) and Hazard Quotient (HQ) values based on toxicity and exposure scenario evaluations.
    Bus JS; Banton MI; Faber WD; Kirman CR; McGregor DB; Pourreau DB
    Crit Rev Toxicol; 2015 Feb; 45(2):142-71. PubMed ID: 25629921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically based pharmacokinetic and pharmacodynamic modeling in health risk assessment and characterization of hazardous substances.
    Leung HW; Paustenbach DJ
    Toxicol Lett; 1995 Sep; 79(1-3):55-65. PubMed ID: 7570674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.